At RFG, our strength comes from our team.
Leo Womack – Founder and Chairman
Leo has spent his entire career in Houston. Beginning as a CPA with Arthur Andersen, he purchased a CPA firm in the Texas Medical Center. In the early 80’s he merged his firm into a large national firm to pursue private investments and entrepreneurial activities and retired from the profession. Leo was a co-founder and CFO of Park Plaza Hospital (376 beds) until it was sold to a NYSE Hospital Management Company. Later he was involved as the financial principal in founding one of the first surgery center companies, a long-term care hospital, and numerous other life science companies primarily in medical device.
He was a founding member of the Houston Angel Network (HAN) and later served as its President and Chairman, and is still an active member. He continues to search for unique opportunities in real estate, early stage technology, medical device, and micro-cap public companies involving these disciplines.
Sepand Moshiri – Managing Director
Sep is a data driven executive and board member with over 20 years of consultative selling and strategic leadership, corporate turnaround, and client operations achievements in the medical devices, disruptive SaaS platform technology, value-based healthcare & services, Big Pharma, and capital markets industries. Sep also built the first and only Elite Customer Service (concierge) model in the Mobile Cardiac Telemetry (MCT) industry.
Involved in various phases of start-ups, funding and acquisitions, Sep serves as a change agent within the cardiovascular innovations industry while executing tactical problem solving solutions. In 2010, he was instrumental in the creation of CardioNexus Corporation (Fairway Medical Technologies & Panasonic NA) to deploy an innovative diagnostic platform. From 2018-19, Sep served as the President of CorVitals of Texas Inc. (now, ARTELLA Solutions Inc.), the pioneering MCT monitoring and Digital Health organization which he co-founded. Currently, he is the Managing Director of Ramsey Financial Group (RFG), a single-family office which manages the Leo B. Womack Family Trust companies and largest shareholder of ARTELLA.
Within management roles in both the Cardiology/Urology and US Government Relations divisions at Pfizer, Inc., Sep developed multi-faceted teams in preparation for launches of emerging first-in-class products throughout leading healthcare systems including VA Medical Centers and The Texas Medical Center. This propelled his significant long-term value at complex matrix medical device organizations. Through his consulting and sales executive roles, Sep led business turnaround in various healthcare entities while enforcing sweeping departmental changes coupled with growing P&L responsibility.
Sep was a founding shareholder and built the Client Operations vertical of the unique mobile 3D Mammography imaging network, Covia Health, whose mission was to define preventative healthcare in women within large-cap employers. At the Utilization Management company WNS-HealthHelp, he oversaw a $60M P&L and led a high performing group to manage 5.2M lives for its largest client, Humana, Inc., while negotiating large Medicare and Commercial Insurance contracts. This served as a precursor to founding and establishing ARTELLA as an Independent Diagnostic Testing Facility (IDTF) to achieve In-Network status with all Payors.
Sep is a Houston Chapter Founder and Co-Chair, Sponsorship Committee of the Private Directors Association (PDA); Board Member at Fairway Medical Technologies; Board Member at ARTELLA; Board Director at Liprostin Group; Business Advisory Board at RedCrow (direct investment platform).
Sep received a Bachelor of Science in Neurobiology with honors from Vanderbilt University and an MBA with highest honors from University of Houston C.T. Bauer College of Business.
Meagan Crawford – Principal
Meagan is an expert in entrepreneurship, with a specific focus on the most exciting new business sector of our time, space commercialization. As an industry veteran and successful entrepreneur, Meagan has been a driving force in the development of the rapidly growing “NewSpace” sector.
In addition to her role as Principal with Ramsey Financial Group (a single-family office), Meagan is also a start-up coach, a mentor, and is Managing Partner at SpaceFund, a venture capital firm investing in NewSpace startups.
Meagan is also a managing team member of the NewSpace Business Plan Competition and a member of the Board of Directors for both the New Worlds Institute and the Space Frontier Foundation. She holds an MBA in Entrepreneurship and Finance from Rice University as well as a BBA in Management and Marketing from the University of Houston. Formerly, she worked at NASA, taught Executive Communication at the University of Houston, and worked as a management consultant in the oil and gas industry.
Bart Womack – Principal
Bart is a company builder, board member, CEO, investor, producer, promoter. Over the last 30 years, Bart has built businesses and executed ideas in a wide range of industries. As a successful and proven entrepreneur, Bart has helped catalyze cultural movements and inspired generations of consumers. Bart is an expert in corporate branding, communications, and business development. With a focus on innovative PR and communications campaigns for start-up companies with limited funds but unlimited inspiration, he is an expert in utilizing every format and platform, from a street level approach to the World Wide Web.
Bart has worked on major motion pictures, produced TV shows, interviewed presidential candidates, and owned the largest, most successful nightclub in the state for over 5 years. He has produced events and concerts with thousands of attendees and he has developed marketing campaigns that reached millions. Bart is a dedicated patron of the arts and sciences. He produced and hosted a public interest TV show, which catalyzed his interest to secure a 501c3 for Houston Media Source, a public access platform for Houston. Then Bart organized a campaign that resulted in the station receiving a 10-year, $12 million grant from the city of Houston and millions in funding from other sources. Bart also volunteers with local organizations and frequently manages communications and media projects for inspirational non-profits, such as the New Worlds Institute. He is the founder of Eden Grow Systems and the Inventor of its first product, The Life Pod.
Over the years RFG has been fortunate to build a collection of highly educated and experienced advisors to assist in developing our projects. Our top advisors include:
Thirza Duensing – Strategic Planning
Thirza brings over 30 years of start-up and enterprise leadership experience in diverse industries, including consumer products, insurance, teleco, cyber security, international sports, healthcare, and high-end design. Her scrutiny and strategic planning across a broad range of real-world applications, has translated concepts into innovative SaaS solutions and successful product introductions.
Thirza is results driven. In leadership roles, she provides innovative insights, optimized programs, and scaled infrastructure on country-wide levels. She is adept in cultivating relationships with intertwined strategies and facilitating high-performing teams in NA, APAC, the UK, and the EU.
Some of the many organizations she has worked with include, Coca-Cola, MasterCard, VISA, Delta Airlines, the Olympic Committee, the World Cup, and IBM. She pursues opportunities that enable her to influence and impact strategic direction, focusing on innovative concepts, sustainability, and business growth for domestic and global organizations that are purpose-driven.
C. Richard Piazza – Life Sciences
Richard marks 35 years of international experience in medical devices, pharmaceuticals, biotech, and healthcare services ranging from start-ups to large multi-nationals. As CEO for AMEX, NASDAQ & TSX companies, he raised $150 million in private and public equity to fund development projects, product introductions, corporate restructurings, and turnarounds for major institutional investors that included JP Morgan Capital. Richard has significant drug, biologic and device development & clinical trial expertise. He was responsible for contracting domestic and international clinical trial sites, tracking those trials, and gaining regulatory approvals for Class I, II & III medical devices, BLA, NDA & ANDAs. His multiple degrees earned from State University of New York, include a BS in Economics, BS in Speech Pathology and PhD studies in Economics. Richard has served as an advisor to MD Anderson Cancer Center Department of Technology Transfer, and as guest lecturer at Caltech, MIT, USC, and Rice University Jones School of Management. He was a partner with La Jolla Capital Partners before relocating to Houston where he continues to work with early stage Life Science companies as an Advisory Board member of BioHouston.
Bruce Badeau – Financial Analysis
Bruce founded First Sovereign Equity Research in 1996, which performs financial modeling, valuations and business planning services for companies seeking to raise capital, or prepare for acquisitions. Bruce is proficient in Excel VBA programming, developed V-Rents©, a business planning software application for Volvo Construction Equipment Rents, and designed and programmed dozens of other financial applications, including a deal making mobile web app: www.sharkcaptable.com. He has structured 80 companies using VentureCAD©, a financial forecasting tool for structuring deals in oil and gas exploration, biotech, pharmaceutical, mobile web apps, robotics, consumer products, autonomous drones, deep-sea drilling equipment, space exploration, and commercial construction. Bruce is a graduate of The Lawrenceville School, earned a B.A. in Economics, University of California Santa Barbara specializing in corporate finance and securities, and completed Bioengineering Management 633 taught by Jack Gill, through the Rice Alliance, at Rice University.
Andrew Nat – Business Development
Andrew is passionate about growing and restructuring businesses and innovation. He has over 30 years of global business experience in the Life Science, Information Technology, and Energy sectors, including expertise in Technology Commercialization, the Capital Markets, Corporate Development, Strategic Planning, M&A, Project Finance, Board Membership, and Deal Execution. During his career, he has closed over $2.6 billion in transactions. Andrew grew Assets Under Management (AUM) 700% for an investment subsidiary and closed $490 million in asset-based investments in the marine, Telcom, aviation and manufacturing industries. He closed more than $66 million in life science technology deals resulting in 8 publicly traded companies and 2 acquisitions.
Currently, Andrew serves as the Managing Partner for ThirdWave Partners, LLC, a consulting firm he founded that focuses on corporate development, technology commercialization, capital raising, and financial and project structuring. He assists private equity firms in evaluating portfolio companies; advises early stage companies on strategy, business development, and fundraising; and acts as an Investment Committee Advisor to a regional seed round fund and an economic development corporation. He also served as a Board Member and Advisor for corporate, non-profit, and government entities.
Andrew earned his MBA from Yale University and his Bachelor of Arts from Columbia University.